Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

BACKGROUND AND PURPOSE The clinical relevance of proton MR spectroscopy needs further clarification as to its usefulness and limitations. The purpose of this study was to investigate the correlation between the semiquantitative choline-containing compound level (Cho value) measured by MR spectroscopy and the Ki-67 labeling index in gliomas. METHODS Localized proton spectra were obtained in 26 consecutive patients with glioma who subsequently underwent surgery for tumor removal. Metabolic values in the spectra were measured semiquantitatively using an external standard of reference. The Ki-67 labeling index was measured in the surgical specimen. Because the semiquantitative metabolic values may be affected by tissue components included in the spectroscopic voxel, the MR imaging appearance of the voxel within the tumor was classed as homogeneous or heterogeneous through visual evaluation of the presence of necrosis, cyst, hemorrhage, and calcification, and pattern of enhancement. RESULTS We found a strong linear correlation between the Cho value and the Ki-67 labeling index in the 18 homogeneous gliomas, but no correlation was found in the eight heterogeneous gliomas, which turned out to be malignant. CONCLUSION The semiquantitative Cho value is a reliable predictor of proliferative activity of gliomas when the tumor appears homogeneous on MR images.

[1]  K. Steck,et al.  Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. , 1994, Cytometry.

[2]  R. Kauppinen,et al.  Quantitative Metabolite Patterns of Human Brain Tumors: Detection by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of computer assisted tomography.

[3]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[4]  P R Luyten,et al.  Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.

[5]  P R Luyten,et al.  Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1h nmr spectroscopic imaging , 1990, Magnetic resonance in medicine.

[6]  F Lazeyras,et al.  Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. , 1996, AJR. American journal of roentgenology.

[7]  J. Voges,et al.  In vivo imaging of glucose consumption and lactate concentration in human gliomas , 1992, Annals of neurology.

[8]  I Mader,et al.  In Vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi‐dimensional classification , 1995, Magnetic resonance in medicine.

[9]  O. G. Dodge,et al.  Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.

[10]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[11]  O. Henriksen,et al.  In VIVO 1H-Spectroscopy of Human Intracranial Tumors at 1.5 Tesla , 1991, Acta radiologica.

[12]  Y. Sonoda,et al.  Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: three technical case reports. , 1999, Neurosurgery.

[13]  M. Oudkerk,et al.  Correlation between choline level and Gd‐DTPA enhancement in patients with brain metastases of mammary carcinoma , 1994, Magnetic resonance in medicine.

[14]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[15]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[16]  D. Jenden,et al.  Localized In Vivo 1H Magnetic Resonance Spectroscopy and In Vitro Analyses of Heterogeneous Brain Tumors , 1995, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[17]  R N Bryan,et al.  In vivo magnetic resonance spectroscopy of human brain tumors , 1993, Topics in magnetic resonance imaging : TMRI.

[18]  W. Heiss,et al.  Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  J C Mazziotta,et al.  Thallium-201 SPECT imaging of brain tumors: methods and results. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[21]  B. Scheithauer,et al.  Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.

[22]  K. Hara,et al.  Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[23]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  C Van Ongeval,et al.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. , 1991, Journal of computer assisted tomography.

[25]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[26]  D. Louis,et al.  Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study , 2004, Acta Neuropathologica.

[27]  B L Miller,et al.  Analysis of brain tumors using 1H magnetic resonance spectroscopy. , 1995, Surgical neurology.

[28]  Charles B. Wilson,et al.  Correlation between the bromodeoxyuridine labeling index and the MIB‐1 and Ki‐67 proliferating cell indices in cerebral gliomas , 1994, Cancer.

[29]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[30]  R. Hawkins,et al.  Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. , 1989, Journal of neurosurgery.